Market Cap

BioMérieux SA Market Capitalization:

€11.41 Billion

EUR as of Jan. 1, 2023

US$12.16 Billion

business BioMérieux SA Company Profile

BioMérieux SA Main Stock Listing

show_chart Euronext: BIM

Market Capitalization History of BioMérieux SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $215.98 B
Danaher $190.92 B
Siemens Healthineers AG $55.11 B
Agilent Technologies, Inc. $44.42 B
DexCom, Inc. $44.32 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Yearly evolution of BioMérieux SA market cap

Date Market Cap YoY Change
Jan. 1, 2023 €11.41 B -7.06%
Jan. 1, 2022 €12.28 B -18.39%
Jan. 1, 2021 €15.04 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

BioMérieux SA Categories

France languages Healthcare languages Diagnostics & Research
France Healthcare France Diagnostics & Research

Stocks & Indices

BioMérieux SA has the following listings and related stock indices.


Stock: Euronext: BIM

Stock: FSX: EYWN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.